These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31200360)

  • 41. An urgent call to raise the bar in oncology.
    Schnog JB; Samson MJ; Gans ROB; Duits AJ
    Br J Cancer; 2021 Nov; 125(11):1477-1485. PubMed ID: 34400802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncology drugs enter the US market faster than in Europe but cost more.
    Mitka M
    JAMA; 2012 Aug; 308(6):555. PubMed ID: 22871850
    [No Abstract]   [Full Text] [Related]  

  • 43. US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
    Rappaport M
    J Oncol Pract; 2016 May; 12(5):397. PubMed ID: 27170686
    [No Abstract]   [Full Text] [Related]  

  • 44. Novel approaches to delivering value in oncology drugs.
    Miller S
    Clin Adv Hematol Oncol; 2016 Apr; 14(4):244-6. PubMed ID: 27166606
    [No Abstract]   [Full Text] [Related]  

  • 45. Can cancer care lead the way toward a value-based future?
    Macmillan K
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249
    [No Abstract]   [Full Text] [Related]  

  • 46. FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug.
    Bach PB; Giralt SA; Saltz LB
    JAMA; 2017 Nov; 318(19):1861-1862. PubMed ID: 28975266
    [No Abstract]   [Full Text] [Related]  

  • 47. Financial Burden of Cancer Drug Treatment in Lebanon.
    Elias F; Khuri FR; Adib SM; Karam R; Harb H; Awar M; Zalloua P; Ammar W
    Asian Pac J Cancer Prev; 2016; 17(7):3173-7. PubMed ID: 27509947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
    Ramsey SD
    J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
    [No Abstract]   [Full Text] [Related]  

  • 49. Review of Current Policy Strategies to Reduce US Cancer Drug Costs.
    Green AK; Ohn JA; Bach PB
    J Clin Oncol; 2020 Feb; 38(4):372-379. PubMed ID: 31804856
    [No Abstract]   [Full Text] [Related]  

  • 50. The drug that could have been.
    Schultz S
    US News World Rep; 2002 Aug; 133(7):18, 20-3. PubMed ID: 12195678
    [No Abstract]   [Full Text] [Related]  

  • 51. Can treatment costs be tamed?
    Malakoff D
    Science; 2011 Mar; 331(6024):1545-7. PubMed ID: 21436438
    [No Abstract]   [Full Text] [Related]  

  • 52. Making precision oncology the standard of care.
    The Lancet Oncology
    Lancet Oncol; 2017 Jul; 18(7):835. PubMed ID: 28677559
    [No Abstract]   [Full Text] [Related]  

  • 53. New Cancer Drug Approvals From the Perspective of a Universal Healthcare System: Analyses of the Pan-Canadian Oncology Drug Review Recommendations.
    Niraula S; Nugent Z
    J Natl Compr Canc Netw; 2018 Dec; 16(12):1460-1466. PubMed ID: 30545993
    [No Abstract]   [Full Text] [Related]  

  • 54. Market watch: Upcoming catalysts in Q1 2015.
    Uribe A
    Nat Rev Drug Discov; 2015 Jan; 14(1):9. PubMed ID: 25503330
    [No Abstract]   [Full Text] [Related]  

  • 55. ASCO Rx for high drug costs: doctors and patients need to talk.
    Nicholas J
    J Natl Cancer Inst; 2009 Nov; 101(21):1441-4. PubMed ID: 19828870
    [No Abstract]   [Full Text] [Related]  

  • 56. Indication-specific Drug Pricing - Simple in Theory, Complex in Reality.
    Kwon S
    Manag Care; 2018 May; 27(5):23-25. PubMed ID: 29763404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacoeconomic analyses make way into oncology.
    Amber D
    J Natl Cancer Inst; 2000 Aug; 92(15):1204-5. PubMed ID: 10922402
    [No Abstract]   [Full Text] [Related]  

  • 58. Ethical and value issues in insurance coverage for cancer treatment.
    Brock DW
    Oncologist; 2010; 15 Suppl 1():36-42. PubMed ID: 20237216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018.
    DeMartino PC; Miljkovic MD; Prasad V
    JAMA Intern Med; 2021 Feb; 181(2):162-167. PubMed ID: 33165499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer care value-learning from others.
    Gamble RB
    Am J Manag Care; 2012 May; 18(3 Spec No.):SP139. PubMed ID: 22642284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.